Member Info for GeneralOz

JCEP, Myles stuck his neck out back on 22nd January.

"The recent convertible bond payment made by Heights will be the last one. We'll see either a 100% conversion and placing out with long-term institutional investors, or else a full repayment in cash - within the next three months."

Well lets hope he's wrong. If a placing covers the Heights bond down at these levels all holders will see some severe dilution. That's not even considering the additional working capital required for P2.

They're not inflators of information. What you get from this company is what it is.

If you want boosters you need a different company. So go and find a different company then?

BV, Avacta don't need to raise funds, they have £18m in the bank. Is your target top up price still 20p?

In fairness to TW, people actually pay to listen to his manipulation. Charles Archer is known to pay others to publish his interviews.

Some of Charles Archer's calls as of late have been straight from TWs playbook. Did he pay TW for the script?

If Ophidian is correct, Avacta has been enrolled onto the FDA's Fast Track program. Very possible that AVA6000 is about to get Fast Track designation.

Charles alludes to the raise being held at 60p and does his best to imply he has inside information. Lines straight out of gravel teeths playbook.

Even Ophidian has a better track record.

And you should take advice from a pizza boy with bad teeth? Or advice from a freelance analyst cuckhold?

Your logic is incomplete, size.

There’s no strategic thinking Ice.

Charles claims Avacta will be lucky to get a 60p placing off the ground. Probably just another twat on the payroll of gravel teeth.

Does seem to throw the 60p figure around like it’s a done deal, though.

How so, Touk?

Avacta would be able to accelerate all pipelines and would never require a placing again. It would be an Nvidia style rise.

Neil Bell might even buy some shares this time.

There could well be a pivotal RNS coming for the diagnostics, Touk.

Avacta have now got direct market access for non Affimer based products. The BOD has created a complete business that will be able generate exquisite revenue streams if there were to be another pandemic.

With the tories out by year end, there'll be no dodgy PPE contracts this time.

If what Ophidian said is correct, there'll be some serious size buying from the directors in the placing.

Bodes well.

"If they do a placing at 60p right now, this should be of no consequence to a long term investor that believes in the company."

Well said Charles. It's a shame this board is full of short term investors (traders) who are worried about placings and evidently don't believe in the company.

Although, Charles is wrong. 60p is far too cheap for a £20mil placing?

The size of ownership question was already addressed.

Directors hold more shares than declared.

At 44mins [LINK REMOVED]

This was addressed in the post AGM presentation back in June.

The directors, especially Shaun Chilton hold a lot more but there is a regulation that prevents the additional shares from being declared.

If Ophidian’s rumour is true, it’s very possible that AVA6000 is on the verge of FDA approval.

Ice, if they went straight to phase 2, what would be the updated timescale for finishing phase 2?

So which one had the job of detecting the Omicron variant?